Acadian Asset Management
VTYX

Acadian Asset Management’s Ventyx Biosciences VTYX Stock Holding History

Acadian Asset Management’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-773,512
Closed -$6.98M – 2270
2025
Q4 		$6.98M Buy
773,512
+69,712
+10% +$521K 0.01% 565
2025
Q3 		$2.18M Buy
703,800
+86,866
+14% +$230K ﹤0.01% 871
2025
Q2 		$1.32M Buy
616,934
+79,880
+15% +$129K ﹤0.01% 925
2025
Q1 		$614K Buy
537,054
+438,286
+444% +$753K ﹤0.01% 1043
2024
Q4 		$215K Sell
98,768
-118,890
-55% -$269K ﹤0.01% 1251
2024
Q3 		$473K Sell
217,658
-45,907
-17% -$106K ﹤0.01% 1104
2024
Q2 		$608K Buy
+263,565
New +$1.1M ﹤0.01% 1135

Other funds holding VTYX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Acadian Asset Management's VTYX Position: Q1 2026 in Review

Acadian Asset Management sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 773,512 shares — an estimated $6.98M sold.

Acadian Asset Management first reported a position in VTYX in Q2 2024 and held it in 7 quarters. The position peaked at $6.98M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Acadian Asset Management reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Acadian Asset Management sold 773,512 Ventyx Biosciences shares in Q1 2026, an estimated $6.98M.
  • Acadian Asset Management first reported a position in Ventyx Biosciences in Q2 2024 and held it in 7 quarters.
  • Acadian Asset Management's Ventyx Biosciences position peaked at $6.98M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.